Concepedia
Statistics
Publications
8
Citations
381
H-Index
Active since
2014
Affiliations
University of Toronto(Current)
Structural Genomics Consortium
Icahn School of Medicine at Mount Sinai
Northwestern University
University of Copenhagen
Kanchan Devkota is an author at University of Toronto specializing in drug discovery, ligand binding, and molecular biology.
Publications per year
2014–2023
The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors
Tomáš Otava, Michal Šála, Fengling Li et al. · ACS Infectious Diseases · 2021 · 94 citations
Pharmacy, Chemistry, Medicinal Chemistry +17
Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors
Kanchan Devkota, Matthieu Schapira, Sumera Perveen et al. · SLAS DISCOVERY · 2021 · 89 citations · Full text
Life Sciences, Molecular Biology, Pharmacology +11
Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase
Isha Singh, Fengling Li, Elissa A. Fink et al. · Journal of Medicinal Chemistry · 2023 · 48 citations · Full text
Pharmacy, Medicinal Chemistry, Molecular Biology +17
Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2
Kanchan Devkota, Brian Lohse, Qing Liu et al. · ACS Medicinal Chemistry Letters · 2014 · 44 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +8
A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19
Sumera Perveen, Aliakbar Khalili Yazdi, Kanchan Devkota et al. · SLAS DISCOVERY · 2021 · 40 citations · Full text
Life Sciences, Infectious Diseases, Molecular Biology +15
1–5 of 8